Numerous studies have revealed a set of core signaling pathways commonly activated in gliomas: the p53 pathway, RB transcriptional corepressor 1 (RB) pathway, and receptor tyrosine kinase (RTK) pathway [17]. This evidence concerns the gene RB1 and central nervous system cancer.